Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

David Micklem

6PUBLICATIONS

35CO-AUTHORS

BiomaterialsHaematological tumoursMolecular targetsCharacterisation of biological macromoleculesGene and molecular therapy

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Sep 26, 2025

Paratope mapping of tilvestamab, an anti-AXL function-blocking antibody, using high-throughput bacterial expression of secreted scFv-osmY fusion proteins.

Eleni Christakou, Petri Kursula, David Micklem

|Jul 22, 2025

A phase 1b, multicentre, dose escalation, safety and pharmacokinetics study of tilvestamab (BGB149) in relapsed, platinum-resistant, high-grade serous ovarian cancer (PROC) patients.

Kenneth Sooi, Tuan Zea Tan, Jae-Weon Kim

|Mar 24, 2025

Bemcentinib as monotherapy and in combination with low-dose cytarabine in acute myeloid leukemia patients unfit for intensive chemotherapy: a phase 1b/2a trial.

Sonja Loges, Michael Heuser, Jörg Chromik

|Dec 17, 2024

AXL-TBK1 driven AKT3 activation promotes metastasis.

Emily N Arner, Dina Alzhanova, Jill M Westcott

|Jul 12, 2024

In vivo turnover and biodistribution of soluble AXL: implications for biomarker development.

Olav Tenstad, Eleni Christakou, Linn Hodneland Nilsson

|Nov 19, 2021

Phosphatidylserine receptors enhance SARS-CoV-2 infection.

Dana Bohan, Hanora Van Ert, Natalie Ruggio

Pageof 1

Frequent Collaborators

3 joint publications

Petri Kursula

2 joint publications

Eleni Christakou

1 joint publications

Dana Bohan

1 joint publications

Hanora Van Ert

1 joint publications

Natalie Ruggio

1 joint publications

José A Aguilar Briseño

1 joint publications

Roberth Anthony Rojas Chavez

1 joint publications

Hillel Haim

1 joint publications

John Minna

1 joint publications

James B Lorens

Frequent Collaborators

3 joint publications

Petri Kursula

2 joint publications

Eleni Christakou

1 joint publications

Dana Bohan

1 joint publications

Hanora Van Ert

Top Related Videos

Direct Detection of Isolevuglandins in Tissues Using a D11 scFv-Alkaline Phosphatase Fusion Protein and Immunofluorescence

Direct Detection of Isolevuglandins in Tissues Using a D11 scFv-Alkaline Phosphatase Fusion Protein and Immunofluorescence

Published on : Jul 05, 2021

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

See more related videos

Top Related Videos

Direct Detection of Isolevuglandins in Tissues Using a D11 scFv-Alkaline Phosphatase Fusion Protein and Immunofluorescence

Direct Detection of Isolevuglandins in Tissues Using a D11 scFv-Alkaline Phosphatase Fusion Protein and Immunofluorescence

Published on : Jul 05, 2021

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

See more related videos